Other languages Pfizer, Inc.

Equities

PFE

US7170811035

Real-time Estimate Cboe BZX Other stock markets 12:18:41 2024-06-06 pm EDT			5-day change	1st Jan Change
29.26 ^USD	-1.00%		+3.88%	+1.75%

Jun. 05	Relay Therapeutics to Collaborate with Pfizer to Evaluate Breast Cancer Treatment	DJ
Jun. 05	Relay Therapeutics to Collaborate With Pfizer to Evaluate Metastatic Breast Cancer Treatment	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Relay Therapeutics to Collaborate With Pfizer to Evaluate Metastatic Breast Cancer Treatment	Jun. 05
COVID shots for JN.1 variant neutralize newer strains, vaccine makers say	Jun. 05
Pfizer : article sur un vaccin contre Lyme dans The Lancet	Jun. 04
Pfizer Partners with Abu Dhabi to Advance Research on Sickle Cell Disease	Jun. 04
Pharmakonzerne müssen sich Zantac-Klagen stellen - Kursrutsch bei GSK	Jun. 03
Takeda Pharmaceutical, Pfizer Say Phase 3 Trial Assessing Blood Cancer Combination Therapy Met Co-Primary Endpoints	Jun. 03
COVID shots should target JN.1, KP.2 subvariants in 2024-25 campaign, US FDA staff says	Jun. 03
Pfizer : essai positif dans le lymphome à grandes cellules B	Jun. 03
Pfizer : essai prometteur dans le lymphome hodgkinien	Jun. 03
GSK und Sanofi unter Druck - US-Sammelklage wegen Zantac	Jun. 03
GSK shares tumble 9% after 70,000 Zantac lawsuits allowed to proceed	Jun. 03
GSK Plans Appeal Against US Judge's Ruling on Jury Trials for Zantac Cases	Jun. 03
Pharmakonzerne müssen sich Zantac-Klagen vor Gericht stellen	Jun. 02
Delaware judge lets more than 70,000 Zantac lawsuits go forward	Jun. 01
Takeda and Pfizer Announce Four-Year Results from Positive Phase 3 HD21 Trial of Additional ADCETRIS (brentuximab vedotin) Combination in Frontline Hodgkin Lymphoma	Jun. 01
Sector Update: Health Care Stocks Higher Late Afternoon	May. 31
Sector Update: Health Care Stocks Advance Friday Afternoon	May. 31
Sector Update: Health Care	May. 31
Pfizer Reports Encouraging Long-Term Trial Results of Advanced Lung Cancer Drug	May. 31
US FDA approves Moderna's RSV vaccine, its second marketed product	May. 31

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Pfizer, Inc: A cycle for nothing?

December 14, 2023 at 10:58 am EST

Albert Bourla, Pfizer CEO (full interview): mRNA, acquisitions, weight-loss drugs

October 31, 2023 at 04:50 pm EDT